Sharda Cropchem Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Sharda Cropchem de 64.1% y 16.1% por año respectivamente. Se prevé que el BPA crezca en un 69.3% al año. Se espera que la rentabilidad financiera sea de 12% en 3 años.
Información clave
73.5%
Tasa de crecimiento de los beneficios
72.1%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Chemicals | 19.0% |
Tasa de crecimiento de los ingresos | 15.8% |
Rentabilidad financiera futura | 12.0% |
Cobertura de analistas | Low |
Última actualización | 15 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Does This Valuation Of Sharda Cropchem Limited (NSE:SHARDACROP) Imply Investors Are Overpaying?
Jun 05What Does Sharda Cropchem Limited's (NSE:SHARDACROP) Share Price Indicate?
Apr 04Need To Know: Analysts Just Made A Substantial Cut To Their Sharda Cropchem Limited (NSE:SHARDACROP) Estimates
Oct 27Analysts Just Made A Major Revision To Their Sharda Cropchem Limited (NSE:SHARDACROP) Revenue Forecasts
Jul 26Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00
Jul 09Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
Jun 07Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00
Jan 27At ₹498, Is Sharda Cropchem Limited (NSE:SHARDACROP) Worth Looking At Closely?
Dec 06Do Sharda Cropchem's (NSE:SHARDACROP) Earnings Warrant Your Attention?
Sep 22Sharda Cropchem's (NSE:SHARDACROP) Dividend Will Be ₹3.00
Jul 20Sharda Cropchem (NSE:SHARDACROP) Will Pay A Dividend Of ₹3.00
Jul 06When Should You Buy Sharda Cropchem Limited (NSE:SHARDACROP)?
Jun 15Is There An Opportunity With Sharda Cropchem Limited's (NSE:SHARDACROP) 41% Undervaluation?
May 31I Ran A Stock Scan For Earnings Growth And Sharda Cropchem (NSE:SHARDACROP) Passed With Ease
May 17Sharda Cropchem (NSE:SHARDACROP) Looks To Prolong Its Impressive Returns
Apr 01We Think Sharda Cropchem (NSE:SHARDACROP) Can Stay On Top Of Its Debt
Mar 03Calculating The Intrinsic Value Of Sharda Cropchem Limited (NSE:SHARDACROP)
Feb 12New Forecasts: Here's What Analysts Think The Future Holds For Sharda Cropchem Limited (NSE:SHARDACROP)
Jan 27Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
Jan 26Sharda Cropchem (NSE:SHARDACROP) Will Be Hoping To Turn Its Returns On Capital Around
Dec 27Increases to CEO Compensation Might Be Put On Hold For Now at Sharda Cropchem Limited (NSE:SHARDACROP)
Jul 22Here's Why I Think Sharda Cropchem (NSE:SHARDACROP) Might Deserve Your Attention Today
Jun 10Is It Time To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
May 26Returns On Capital At Sharda Cropchem (NSE:SHARDACROP) Have Hit The Brakes
May 12Are You An Income Investor? Don't Miss Out On Sharda Cropchem Limited (NSE:SHARDACROP)
Apr 13We Think Sharda Cropchem (NSE:SHARDACROP) Can Manage Its Debt With Ease
Mar 30Has Sharda Cropchem Limited (NSE:SHARDACROP) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Mar 16Have Insiders Been Buying Sharda Cropchem Limited (NSE:SHARDACROP) Shares?
Mar 01Should You Think About Buying Sharda Cropchem Limited (NSE:SHARDACROP) Now?
Feb 18Should You Be Adding Sharda Cropchem (NSE:SHARDACROP) To Your Watchlist Today?
Feb 08Results: Sharda Cropchem Limited Beat Earnings Expectations And Analysts Now Have New Forecasts
Jan 28Is Sharda Cropchem (NSE:SHARDACROP) Likely To Turn Things Around?
Jan 27Reflecting on Sharda Cropchem's (NSE:SHARDACROP) Share Price Returns Over The Last Three Years
Jan 18Key Things To Understand About Sharda Cropchem's (NSE:SHARDACROP) CEO Pay Cheque
Jan 06Why Sharda Cropchem Limited (NSE:SHARDACROP) Should Be In Your Dividend Portfolio
Dec 28Sharda Cropchem (NSE:SHARDACROP) Is Growing Earnings But Are They A Good Guide?
Dec 17We Think Sharda Cropchem (NSE:SHARDACROP) Can Manage Its Debt With Ease
Dec 07Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
3/31/2026 | 43,284 | 3,112 | 1,618 | 4,947 | 5 |
3/31/2025 | 35,845 | 2,273 | 1,029 | 4,021 | 4 |
3/31/2024 | 31,630 | 319 | 692 | 3,413 | N/A |
12/31/2023 | 32,996 | 873 | N/A | N/A | N/A |
9/30/2023 | 37,176 | 1,910 | 785 | 3,267 | N/A |
6/30/2023 | 38,584 | 2,307 | N/A | N/A | N/A |
3/31/2023 | 40,452 | 3,420 | 842 | 3,283 | N/A |
12/31/2022 | 39,978 | 3,201 | N/A | N/A | N/A |
9/30/2022 | 38,603 | 3,139 | -565 | 2,064 | N/A |
6/30/2022 | 38,019 | 3,338 | N/A | N/A | N/A |
3/31/2022 | 35,798 | 3,493 | 333 | 2,671 | N/A |
12/31/2021 | 32,334 | 3,062 | N/A | N/A | N/A |
9/30/2021 | 28,474 | 2,523 | 1,084 | 3,349 | N/A |
6/30/2021 | 26,294 | 2,394 | N/A | N/A | N/A |
3/31/2021 | 23,956 | 2,292 | 152 | 2,464 | N/A |
12/31/2020 | 21,835 | 2,369 | N/A | N/A | N/A |
9/30/2020 | 20,722 | 1,945 | 1,144 | 2,972 | N/A |
6/30/2020 | 19,714 | 1,698 | N/A | N/A | N/A |
3/31/2020 | 20,030 | 1,647 | -297 | 1,463 | N/A |
12/31/2019 | 18,943 | 1,286 | N/A | N/A | N/A |
9/30/2019 | 19,824 | 1,431 | 1,925 | 3,855 | N/A |
6/30/2019 | 19,680 | 1,649 | N/A | N/A | N/A |
3/31/2019 | 19,976 | 1,763 | 4,131 | 5,561 | N/A |
12/31/2018 | 20,072 | 1,840 | N/A | N/A | N/A |
9/30/2018 | 18,612 | 1,736 | N/A | N/A | N/A |
6/30/2018 | 18,294 | 1,818 | N/A | N/A | N/A |
3/31/2018 | 17,066 | 1,908 | -1,848 | 170 | N/A |
12/31/2017 | 15,396 | 1,763 | N/A | N/A | N/A |
9/30/2017 | 14,571 | 1,840 | N/A | N/A | N/A |
6/30/2017 | 14,257 | 1,927 | N/A | N/A | N/A |
3/31/2017 | 13,992 | 1,904 | N/A | 1,815 | N/A |
12/31/2016 | 13,229 | 1,918 | N/A | N/A | N/A |
9/30/2016 | 12,663 | 1,861 | N/A | N/A | N/A |
6/30/2016 | 12,563 | 1,795 | N/A | N/A | N/A |
3/31/2016 | 12,221 | 1,751 | N/A | 1,966 | N/A |
12/31/2015 | 10,356 | 1,167 | N/A | N/A | N/A |
9/30/2015 | 10,402 | 1,136 | N/A | N/A | N/A |
6/30/2015 | 10,697 | 1,159 | N/A | N/A | N/A |
3/31/2015 | 10,616 | 1,230 | N/A | 461 | N/A |
12/31/2014 | 10,015 | 1,242 | N/A | N/A | N/A |
9/30/2014 | 9,605 | 1,207 | N/A | N/A | N/A |
6/30/2014 | 8,764 | 1,237 | N/A | N/A | N/A |
3/31/2014 | 7,904 | 1,111 | N/A | 1,563 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (64.1% al año) de SHARDACROP es superior a la tasa de ahorro (6.7%).
Beneficios vs. Mercado: Se prevé que los beneficios (64.1% al año) de SHARDACROP crezcan más rápidamente que el mercado Indian (17.8% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de SHARDACROP crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (16.1% al año) de SHARDACROP crezcan más rápidamente que los del mercado Indian (10.3% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 16.1% al año) de SHARDACROP crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de SHARDACROP sea baja dentro de 3 años (12%).